Aprea Therapeutics
APRE
#11121
Rank
A$4.9 M
Marketcap
A$0.35
Share price
-53.56%
Change (1 day)
-80.90%
Change (1 year)

Earnings for Aprea Therapeutics (APRE)

Earnings in 2026 (TTM): -A$19.46 Million

According to Aprea Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$20 Million, an increase over its 2024 earnings that were of -A$21.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aprea Therapeutics from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$19.46 Million-2.71%
2025 -A$20 Million-7.58%
2024 -A$21.64 Million-7.45%
2023 -A$23.38 Million-58.6%
2022 -A$56.47 Million-0.2%
2021 -A$56.58 Million-29.09%
2020 -A$79.79 Million64.34%
2019 -A$48.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Magellan Health
MGLN
A$32.37 M-262.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
A$0.22 B-1,229.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
A$0.19 B-1,079.35%๐Ÿ‡บ๐Ÿ‡ธ USA